Share
News

Health Department Orders 'Non-White' Patients Be Given Priority Access to New COVID Drug That Is in Limited Supply

Share

The New York City Department of Health and Mental Hygiene is requiring health care providers to prioritize non-white patients when administering oral antiviral treatment for COVID-19.

The department issued a health advisory notice Monday announcing that the Food and Drug Administration approved paxlovid and molnupiravir as oral antiviral treatments for the coronavirus, and it provided the eligibility criteria for receiving the drugs.

The criteria state that the drugs are authorized for patients who meet all of the stated criteria, which include patients who “have a medical condition or other factors that increase their risk for severe COVID-19 illness.” The department then noted that “Black, Indigenous, and People of Color” are at “increased risk of severe COVID-19 outcomes and death” and told health care providers to “consider race and ethnicity when assessing an individual’s risk.”

More, the notice ordered providers to adhere to the department’s COVID-19 guidance for prioritizing anti-COVID-19 antivirals as well as monoclonal antibody treatment products. This guidance explicitly lists non-white ethnicity as a risk factor, and it instructs providers to prioritize non-white people when administering treatment.

“Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from COVID-19,” the guidance reads.

Trending:
Family Forced to Scale Back Hunt for Missing Daughter After People Blaming Parents Infiltrate Search Parties

According to the department’s prioritization guidance, individuals with risk factors receive priority treatment over individuals without risk factors. Individuals without risk factors are at the lowest level of priority for receiving treatment.

In a notification sent to health care providers and facilities, the department echoed its risk assessment, informing providers that those who can receive the antiviral treatments must meet all the eligibility criteria.

The New York State Department of Health did not respond to the Daily Caller News Foundation’s request for comment.

New York’s guidance echoes the risk assessment made by the Centers for Disease Control and Prevention, which states that  “long-standing systemic health and social inequities have put various groups of people at increased risk of getting sick and dying from COVID-19, including many people from certain racial and ethnic minority groups and people with disabilities.”

The CDC initially proposed prioritizing vaccinating essential workers over the elderly in order to be more racially equitable as the elderly are more likely to be white and essential workers are less likely to be white, despite the fact that the elderly face greater risks from COVID-19.

The National Institutes of Health unveiled a plan in June to fund research projects into “structural racism” in medicine and health sciences.

Content created by the Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of the DCNF’s original content, please contact licensing@dailycallernewsfoundation.org.

A version of this article appeared on the Daily Caller News Foundation website.

Truth and Accuracy

Submit a Correction →



We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

Share
Founded by Tucker Carlson, a 25-year veteran of print and broadcast media, and Neil Patel, former chief policy adviser to Vice President Dick Cheney, The Daily Caller News Foundation is a 501(c)(3) non-profit providing original investigative reporting from a team of professional reporters that operates for the public benefit.




Conversation